Life Sciences Clinical and R&D IT Services – Service Provider Landscape with PEAK Matrix™ Assessment 2015

30 Oct 2015
by Abhishek Singh, Jimit Arora, Mayank Maria, Nitish Mittal



The healthcare landscape has been subject to significant turbulence on account of a gamut of factors, including escalating costs, widespread regulatory amendments, changing business models, and the evolution of the patient-centric paradigm (with mobile computing, social media platforms, and “anytime-anywhere” information access). This combination of disruptive and legacy factors has driven healthcare firms to adopt new technologies, and at the same time revamp their existing systems, processes, and interfaces.

As the technology mandate for healthcare enterprises evolves, so do their relationships with IT service providers. This, in turn, is driving the need for relevant research and market intelligence on demand and supply trends in healthcare outsourcing across the three major market segments – payer, provider, and life sciences. Everest Group’s Healthcare and Life Sciences (HLS) IT research program addresses this market’s requirement by analyzing outsourcing trends and service provider capabilities specific to HLS IT.

In this report, we analyze the capabilities of 16 IT service providers specific to clinical and R&D IT services in the global life sciences space. These service providers are mapped on the Everest Group Performance | Experience | Ability | Knowledge (PEAK) Matrix, which is a composite index of a range of distinct metrics related to a provider’s capability and market success.


Scope of the analysis

  • Industry: Life sciences (pharmaceuticals, medical devices, biotechnology, and other life sciences)
  • Services: Clinical and R&D IT services
  • Geography: Global
  • Sourcing model: Third-party IT transactions; excludes shared services or Global In-house Centers (GICs)

Value Chain


This report is structured across four key sections, each providing insights into the life sciences clinical and R&D IT service provider landscape, with a specific focus on large-sized contracts:

  • Clinical and R&D in life sciences
    • Key themes
    • Clinical and R&D IT framework – scope vs. enablers
    • Value chain adoption
    • Service lines driving IT demand across categories
    • Deal analysis
  • Life sciences clinical and R&D IT service provider landscape: Analysis of individual service provider capabilities in the life sciences clinical and R&D IT space along the following dimensions:
    • Delivery capability:
      • Scale
      • Scope
      • Domain investments
      • Delivery footprint
      • Innovation
      • Buyer satisfaction
    • Market success:
      • Transaction activity
  • Life sciences clinical and R&D IT PEAK Matrix 2015 and analysis of individual Matrix clusters:
    • Mapping of life sciences clinical and R&D IT service providers on the Everest Group Performance | Experience | Ability | Knowledge (PEAK) Matrix
    • Commentary on the specific characteristics of PEAK Matrix clusters (Leaders, Major Contenders, and Aspirants)
    • Commentary on the capabilities of each service provider:
      • Delivery capability characteristics (scale, scope, domain investments, delivery footprint, innovation, and buyer satisfaction)
      • Market success characteristics (transaction activity)
  • Implications for key stakeholders: Implications of the market dynamics and identified life sciences clinical and R&D IT service provider landscape characteristics for key stakeholders:
    • Implications for service providers
    • Implications for buyers

Everest Group has a complimentary four-page PEAK Matrix preview document for this service provider landscape report.


Page Count: 52